Shearman & Sterling advised CVS Health, while Simpson Thacher advised the underwriters led by Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC, on...
CVS Health’s $1 Billion Debt Offering
CVS Health’s $2.05 Billion Debt Tender Offers
Shearman & Sterling advised CVS Health, while Simpson Thacher advised Barclays, Goldman Sachs and Wells Fargo Securities, LLC as dealer managers, on the deal. CVS Health...
NOVA Chemicals Corporation’s $575 Million Senior Notes Offering and $500 Million Tender Offer
Shearman & Sterling represented HSBC Securities (USA) and the other initial purchasers in the offering, and tender offer and consent solicitation. NOVA Chemicals Corporation executed its offering...
Genpact’s $350 Million Senior Notes Offering
Cravath represented Genpact Luxembourg S.à r.l. and Genpact USA, Inc., while Shearman & Sterling represented the underwriters in the offering. Genpact Luxembourg S.à r.l. and Genpact...
Ibere Pharmaceuticals’ $138 Million Initial Public Offering
Shearman & Sterling advised Ibere Pharmaceuticals on the deal. Ibere Pharmaceuticals, a blank check company formed for the purpose of effecting a merger in the pharmaceutical...
Intercontinental Exchange’s $11 Billion Acquisition of Ellie Mae
Shearman & Sterling LLP served as the legal advisor to Intercontinental Exchange, with additional legal advice from Morgan, Lewis & Bockius LLP, Potter Anderson & Corroon...